Elisha M. Wachman, MD
Associate Professor
Boston University School of Medicine
Dept of Pediatrics
Neonatology

MD, Boston University School of Medicine




Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research interests include the genetics and epigenetics of NAS, breastfeeding in the setting of maternal substance use disorders, and the use of non-pharmacologic care methods to improve NAS outcomes. She is the neonatal lead of the Massachusetts (MA) neoQIC NAS Quality Improvement Collaborative. She was a site investigator in a NIDA funded clinical trial comparing the short-term and long-term outcomes of methadone versus morphine for NAS and is currently the principal investigator of a NICHD funded study examining the safety, efficacy, pharmacokinetics, pharmacogenomics, and long-term maternal and infant outcomes of extended-release naltrexone for pregnant women with opioid use disorder.

2018 America's Essential Hospitals Gage Award



The National Drug Abuse Treatment Clinical Trials Network (CTN-0080
06/01/2019 - 02/28/2024 (PI)
McLean Hospital NIH-NIDA

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with…
09/17/2018 - 05/31/2023 (PI)
NIH-NICHD
1R01HD096798-01

Neonatal Abstinence Syndrome (NAS) Research and Quality Improvement Program
12/14/2016 - 08/31/2018 (PI)
Massachusetts Health Policy Commission


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Singh R, Houghton M, Melvin P, Wachman EM, Diop H, Iverson R, Picarillo A, Rhein L, Gupta M. Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database. J Perinatol. 2021 Feb 19. PMID: 33608626
     
  2. Benarroch Y, Juttukonda L, Sabharwal V, Boateng J, Khan AR, Yarrington C, Wachman EM, Taglauer E. Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019. Clin Ther. 2021 Jan 08.View Related Profiles. PMID: 33541739
     
  3. Meyers S, Wachman EM. A Case of False-positive Amphetamine Results on Urine Toxicology Testing Secondary to Imatinib. J Addict Med. 2020 Nov 10. PMID: 33181576
     
  4. Peeler M, Gupta M, Melvin P, Bryant AS, Diop H, Iverson R, Callaghan K, Wachman EM, Singh R, Houghton M, Greenfield SF, Schiff DM. Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019). Am J Public Health. 2020 12; 110(12):1828-1836.View Related Profiles. PMID: 33058701
     
  5. Harris M, Joseph K, Hoeppner B, Wachman EM, Gray JR, Saia K, Wakeman S, Bair-Merritt MH, Schiff DM. A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation. J Addict Med. 2020 Oct 14.View Related Profiles. PMID: 33060464
     
  6. Taglauer E, Benarroch Y, Rop K, Barnett E, Sabharwal V, Yarrington C, Wachman EM. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta. 2020 10; 100:69-74.View Related Profiles. PMID: 32862058
     
  7. Sen S, Andrews C, Anderson E, Turner D, Monthé-Drèze C, Wachman EM. Type of feeding provided with dextrose gel impacts hypoglycemia outcomes: comparing donor milk, formula, and breastfeeding. J Perinatol. 2020 Nov; 40(11):1705-1711. PMID: 32792637
     
  8. Wachman EM, Houghton M, Melvin P, Isley BC, Murzycki J, Singh R, Minear S, MacMillan KDL, Banville D, Walker A, Mitchell T, Galimi-Hayes R, Jorgensen S, Gomes DR, Hodgins F, Whalen BL, Diop H, Gupta M. A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts' PNQIN collaborative. J Perinatol. 2020 Oct; 40(10):1560-1569.View Related Profiles. PMID: 32678314
     
  9. Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Letter-in-reply. J Addict Med. 2020 Jul/Aug; 14(4):354-355. PMID: 31972769
     
  10. Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C. Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemp Clin Trials. 2020 06; 93:106014.View Related Profiles. PMID: 32353544
     
Showing 10 of 46 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 46 publications over 11 distinct years, with a maximum of 10 publications in 2020

YearPublications
20102
20111
20131
20142
20153
20164
20174
20189
20198
202010
20212


Recent (within 3 months)

Pregnant people infected with SARS-CoV-2 appear to be at higher risk of developing severe cases of COVID-19 than infected people who are not pregnant.

Technology.org 1/5/2021

Human Fetuses Can Contract SARS-CoV-2, but It’s Rare

The Scientist 1/1/2021

Older

Researchers Identify Proteins That Prevent COVID-19 Transmission Through the Placenta

HealthCity 9/15/2020

Implementing Eat, Sleep, Console Model Improves Neonatal Opioid Withdrawal Syndrome Outcomes

HealthCity 9/2/2020

Pilot Study: Treating Opioid Use Disorder with Naltrexone During Pregnancy Shows Promise

MultiBrief Exclusive 9/19/2019

Using Naltrexone During Pregnancy Can Benefit Infants, Moms

The Fix 8/21/2019

BMC: Naltrexone Promising Treatment for Opioid Use Disorder During Pregnancy

Essential Hospitals 8/14/2019

Naltrexone May Offer Advantages Over Buprenorphine to Treat Opioid Use Disorder During Pregnancy

HealthCity 8/13/2019

Promotion to Associate Professor for 18 Medical Campus Faculty

BU Today 6/14/2019

‘Hugs Not Drugs’ for Opioid-Dependent Newborns

MedPage Today 4/30/2019

To The Moon And Back, SENSE Host Newborne Substance Abuse Event

Wicked Local Carve 4/23/2019

Buprenorphine Optimal Treatment For Neonatal Abstinence Syndrome

Healio 2/2/2019

Buprenorphine May Best Morphine for Treating NAS

MedPage Today 1/22/2019

‘I Know I Can Do It’: New Hampshire Moms In Recovery Learn New Methods Of Supporting Babies

The Boston Globe 10/15/2018

Amid opioid crisis, treatment for dependent infants evolves

The Columbian 8/27/2018

Babies Born Dependent On Opioids Need Touch, Not Tech

WBUR 8/16/2018
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Neonatal Abstinence Syndrome
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Wachman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department